Responses
Regular and young investigator award abstracts
Clinical trials completed
277 Combined neoadjuvant chemo-immunotherapy therapy achieves superior downstaging of resectable non-small cell lung cancer as compared to chemotherapy, mono or dual immunotherapy
Compose a Response to This Article
Other responses
No responses have been published for this article.